KYTH Key Stats
- Nasdaq stocks posting largest percentage increases May 13
- Kythera Biophrm (KYTH) Posts Q1 Loss of 77c/Share Street Insider May 13
- KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results GlobeNewswire May 13
- KYTHERA BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Fin... May 13
- Q1 2013 Kythera Biopharmaceuticals Earnings Release - Time Not Supplied May 13
- KYTHERA Biopharmaceuticals to Present at Bank of America Merrill Lynch 2013 Heal... May 7
- KYTHERA Biopharmaceuticals to Release First Quarter 2013 Operating Results noodls May 2
- KYTHERA BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events Apr 25
- Bearish MACD for Kythera Biopharmaceuticals Inc. - Tale of the Tape Zacks Apr 24
- KYTHERA Biopharmaceuticals Presents Positive MRI Results from Phase IIb Study of... Apr 13
KYTH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). KYTHERA Biopharmaceuticals is up 0.00% over the last year vs S&P 500 Total Return up 30.71%, Cyanotech Corporation down 29.51%, and Intercept Pharmaceuticals up 0.00%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for KYTH
Pro Report PDF for KYTH
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download KYTH Pro Report PDF
Pro Strategies Featuring KYTH
Did KYTHERA Biopharmaceuticals make it into our Pro Portfolio Strategies?